Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

The life science sector brought about €29.7 billion ($34.41 billion) and €8.9 billion ($10.31 billion) in gross value added in 2024, according to a report by the Portuguese Trade & Investment Agency.

According to the World Health Organization (WHO), breast cancer was the most common cancer in women in 157 countries out of 185 in 2022, with incidence rates found to be rising by 1% per year overall ...

For a long time, neurological drug development has largely focused on the cells that ultimately die or malfunction. Alzheimer’s researchers chased amyloid and tau. Parkinson’s drug development ...

Scientists have long been studying how to turn viruses into cancer-fighting tools, prompting the rise of a form of immunotherapy involving oncolytic viruses. These viruses are specially engineered to ...

For years, STAT6, a key transcription factor in allergic diseases like asthma and atopic dermatitis, was considered off-limits. Traditional small molecules couldn’t get a grip on it. There were no ...